Document is current

Any future updates will be listed below

Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

Crossref DOI link: https://doi.org/10.1038/s41392-021-00643-y

Published Online: 2021-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark